The drug price deal between Pfizer and the Trump administration was built on down-to-the-wire team negotiations, building on a relationship between CEO Albert Bourla and President Trump

The recent drug price deal between Pfizer and the Trump administration highlights the successful negotiations led by CEO Albert Bourla and President Trump. This agreement is significant as it reflects a collaborative effort to address drug pricing, which has been a pressing issue for many Americans. The relationship between Bourla and Trump played a crucial role in reaching this deal, showcasing how strategic partnerships can lead to impactful policy changes.